1 Anti-obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-obesity Drugs
1.2 Anti-obesity Drugs Segment by Type
1.2.1 Global Anti-obesity Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Peripherally Acting Anti-obesity Drugs
1.2.3 Centrally Acting Anti-obesity Drugs
1.3 Anti-obesity Drugs Segment by Application
1.3.1 Global Anti-obesity Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Kids
1.3.3 Adults
1.4 Global Anti-obesity Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-obesity Drugs Revenue 2017-2028
1.4.2 Global Anti-obesity Drugs Sales 2017-2028
1.4.3 Anti-obesity Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-obesity Drugs Market Competition by Manufacturers
2.1 Global Anti-obesity Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Anti-obesity Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Anti-obesity Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-obesity Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-obesity Drugs Players Market Share by Revenue
2.5.3 Global Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-obesity Drugs Retrospective Market Scenario by Region
3.1 Global Anti-obesity Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Anti-obesity Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Anti-obesity Drugs Market Facts & Figures by Country
3.3.1 North America Anti-obesity Drugs Sales by Country
3.3.2 North America Anti-obesity Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-obesity Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-obesity Drugs Sales by Country
3.4.2 Europe Anti-obesity Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-obesity Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-obesity Drugs Sales by Region
3.5.2 Asia Pacific Anti-obesity Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-obesity Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-obesity Drugs Sales by Country
3.6.2 Latin America Anti-obesity Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-obesity Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-obesity Drugs Sales by Country
3.7.2 Middle East and Africa Anti-obesity Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-obesity Drugs Historic Market Analysis by Type
4.1 Global Anti-obesity Drugs Sales Market Share by Type (2017-2022)
4.2 Global Anti-obesity Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Anti-obesity Drugs Price by Type (2017-2022)
5 Global Anti-obesity Drugs Historic Market Analysis by Application
5.1 Global Anti-obesity Drugs Sales Market Share by Application (2017-2022)
5.2 Global Anti-obesity Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Anti-obesity Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Anti-obesity Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Novo Nordisk Anti-obesity Drugs Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Anti-obesity Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Arena Pharmaceuticals
6.4.1 Arena Pharmaceuticals Corporation Information
6.4.2 Arena Pharmaceuticals Description and Business Overview
6.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Arena Pharmaceuticals Anti-obesity Drugs Product Portfolio
6.4.5 Arena Pharmaceuticals Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Roche Anti-obesity Drugs Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 GlaxoSmithKline Anti-obesity Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Orexigen Therapeutics
6.6.1 Orexigen Therapeutics Corporation Information
6.6.2 Orexigen Therapeutics Description and Business Overview
6.6.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Orexigen Therapeutics Anti-obesity Drugs Product Portfolio
6.7.5 Orexigen Therapeutics Recent Developments/Updates
6.8 Vivus
6.8.1 Vivus Corporation Information
6.8.2 Vivus Description and Business Overview
6.8.3 Vivus Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Vivus Anti-obesity Drugs Product Portfolio
6.8.5 Vivus Recent Developments/Updates
6.9 Amylin
6.9.1 Amylin Corporation Information
6.9.2 Amylin Description and Business Overview
6.9.3 Amylin Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Amylin Anti-obesity Drugs Product Portfolio
6.9.5 Amylin Recent Developments/Updates
6.10 Alizyme
6.10.1 Alizyme Corporation Information
6.10.2 Alizyme Description and Business Overview
6.10.3 Alizyme Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Alizyme Anti-obesity Drugs Product Portfolio
6.10.5 Alizyme Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Anti-obesity Drugs Description and Business Overview
6.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Boehringer Ingelheim Anti-obesity Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Eisai
6.12.1 Eisai Corporation Information
6.12.2 Eisai Anti-obesity Drugs Description and Business Overview
6.12.3 Eisai Anti-obesity Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Eisai Anti-obesity Drugs Product Portfolio
6.12.5 Eisai Recent Developments/Updates
7 Anti-obesity Drugs Manufacturing Cost Analysis
7.1 Anti-obesity Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-obesity Drugs
7.4 Anti-obesity Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-obesity Drugs Distributors List
8.3 Anti-obesity Drugs Customers
9 Anti-obesity Drugs Market Dynamics
9.1 Anti-obesity Drugs Industry Trends
9.2 Anti-obesity Drugs Market Drivers
9.3 Anti-obesity Drugs Market Challenges
9.4 Anti-obesity Drugs Market Restraints
10 Global Market Forecast
10.1 Anti-obesity Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-obesity Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Anti-obesity Drugs by Type (2023-2028)
10.2 Anti-obesity Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-obesity Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Anti-obesity Drugs by Application (2023-2028)
10.3 Anti-obesity Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-obesity Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Anti-obesity Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
